Acute Myeloid Leukemia (AML) — Classification and Survival Rate
Acute myeloid leukemia (AML) is caused by malignant transformation of the hematopoietic stem cells. It is predominantly seen in individuals between the ages of 50 and 60 years and is characterized by the arrest of leukocyte development in the early stage of development. Diagnosis is based on the presence of blast cells in the peripheral circulation. AML is treated by chemotherapy, which includes treatment of remission and post-induction remission. Refractory cases of AML are treated by bone marrow transplants. Complications of AML include anemia, infections, and bleeding as well as acute medical emergencies such as necrotizing enterocolitis, hyperleukocytosis, and tumor lysis syndrome. Table of Contents Definition of Acute Myeloid Leukemia Epidemiology & Etiology of Acute Myeloid Leukemia Classification of Acute Myeloid Leukemia Pathophysiology of Acute Myeloid Leukemia Clinical Examination and Symptoms of Acute Myeloid Leukemia Diagnosis of Acute Myeloid Leukemia Th